Medical 21, Inc. — Form D/A

Medical 21, Inc. of Plymouth, MN, a company, filed a Form D amendment with the SEC on 2023-07-31. The offering totals $10.0M, of which $1.9M was reported sold. Industry: Biotechnology.

Offering

Filed: 2023-07-31
Form: D/A
Accession: 0001437749-23-021196
Industry: Biotechnology
Exemptions: 06b
Total offering: $10.0M
Amount sold: $1.9M
Remaining: $8.1M
Investors: 17
Date of first sale: 2023-02-09
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-478939

Issuer

Name: Medical 21, Inc.
CIK: 0001673688
Entity type: Corporation
Jurisdiction: MINNESOTA
Incorporated: 2016
Address: 3700 Annapolis Lane North, Plymouth, MN, 55447
Phone: 612-670-5507

Officers, directors & promoters (9)

Name	Role	Location
Eric Solien	Executive Officer	Plymouth, MN
Eric Solien	Promoter	Plymouth, MN
Erik Hermansen	Executive Officer	Plymouth, MN
Chaid Schwarz	Executive Officer	Plymouth, MN
Manny Villafana	Director	Plymouth, MN
Manny Villafana	Executive Officer	Plymouth, MN
Manny Villafana	Promoter	Plymouth, MN
Jeff Vreeman	Executive Officer	Plymouth, MN
Andrea Sweeney	Executive Officer	Plymouth, MN

Other filings by this issuer (10)

Filed	Form	Offering	Sold
2025-08-21	D/A	$20.0M	$10.0M
2024-07-29	D/A	$10.0M	$5.2M
2023-04-14	D	$10.0M	$430K
2022-09-20	D	$20.0M	$2.5M
2021-01-12	D/A	$10.0M	$3.0M
2020-01-16	D/A	$10.0M	$1.1M
2019-01-08	D	$10.0M	—
2018-08-01	D	$4.0M	$750K
2017-09-01	D	$15.0M	$250K
2016-05-19	D	$2.0M	$200K

More